Bringing you the Best Analytical Legal News
The transaction involves multidisciplinary legal advice spanning M&A, employment, tax, data privacy, and equity compensation matters.
The transaction resulted in a change of control and triggered a mandatory open offer under SEBI takeover regulations, alongside structured acquisition financing.
The IPO comprised a fresh issue and an offer for sale, with IFC divesting part of its shareholding. Nephrocare’s equity shares were listed on Indian stock exchanges on 17 December 2025.
The transaction grants Saregama a significant minority equity stake in Bhansali Productions along with exclusive music rights for all future Bhansali films.
The transaction strengthens Lighthouse Learning’s position as a leading Indian education services provider. CAM advised on corporate, diligence, real estate, employment, disputes, finance, and competition aspects of the deal.
The transaction marks the first phase of consolidating L&T’s real estate assets into a unified entity positioned for India’s growing property market.
The firm advised prominent investors such as Elevation Capital, Peak Investments, Venture Highway, and Y Combinator. The issue opened on December 3 and closed on December 5, 2025.
Cyril Amarchand Mangaldas advised Sheela Foam Limited on further investment in Furlenco via preferential issue and structuring investor rights in the funding round.
Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at ₹2,250 crore. The deal marks a significant restructuring in India’s biopharmaceutical sector.
CAM advised Ashoka Buildcon Limited on Macquarie’s ~₹1,715 crore exit from its group entities, providing end-to-end transactional support on the divestment of stakes in Ashoka Concessions Limited and Jaora—Nayagaon Toll Road Company Private Limited.
The Panel upheld Coinswitch’s claim on all three UDRP criteria, finding confusing similarity, lack of legitimate rights, and bad faith registration and use.
Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.
CAM advised Goldman Sachs (India) Securities Private Limited as placement agent in the ₹7,191 crore sale of 34.3 million equity shares of Bharti Airtel Limited by Indian Continent Investment Limited, executed through on-screen block trades on BSE and NSE.
The deal involves an initial USD 2 billion equity commitment, with an additional USD 4—5 billion planned through debt, marking one of India’s largest private equity investments in the digital infrastructure sector.
The firm advised on transactional, regulatory, and data-privacy aspects, with the deal signed on 16 May 2025 and completed on 6 October 2025. Fisdom provides mutual fund, stockbroking, PMS, and tax-filing services.
The firm’s Capital Markets and sectoral experts guided the BRLMs, Kotak, J.P. Morgan, Goldman Sachs and Axis Capital, through the transaction, which opened on 11 November 2025.
Cyril Amarchand Mangaldas advised the book running lead managers on the ₹66,230 million IPO of Billionbrains Garage Ventures Limited (Groww), which saw strong investor demand with an overall subscription of 17.60 times.
Cyril Amarchand Mangaldas advised Pine Labs Limited on its ₹38,999.08 million IPO and the reverse merger of its Singapore holding company into the Indian entity, handling NCLT/NCLAT filings, regulatory clearances, and all aspects of the offering.
Cyril Amarchand Mangaldas advised Lenskart Solutions Limited and its promoters on the company’s ₹72,780 million IPO comprising a fresh issue and offer for sale, marking one of the most significant public offerings in the Indian retail tech sector.
Vanya Singh has over 18 years of experience in securities and capital markets law and regulation with SEBI. She has worked across the quasi-judicial, policy, legal affairs and enforcement departments.